Technology

AspyreRx™, prescribed in 90-day increments, resulted in a mean HbA1c reduction of 1.3% at 180 days in 1 out of 2 phase 3 trial participants. A Q4 launch is anticipated.

The certification is available to all health care professionals and aims to standardize training and increase skills in telehealth care delivery and integration into practice.

Your daily dose of clinical news you may have missed.

Try this 7-question quiz on the 2023 guidelines from The Endocrine Society that focus on advances in diabetes treatment that help minimize risk of hypoglycemia.

Mean time in range increased by ~10% and time above range decreased by 8.1% in study participants taking as few as a single antihyperglycemic medication.

Prescriptions for continuous glucose monitoring for patients with T2D are increasing, a new study finds, and the authors report on characteristics of new CGM users.

Your daily dose of clinical news you may have missed.

Findings from new study demonstrate the potential benefits of continuing telehealth services and medications for opioid use disorder.

Your daily dose of clinical news you may have missed.

An Apple Watch feature designed to detect atrial fibrillation was associated with a low rate of false-positive detections and high specificity in persons with AF.